Use of Chinese medicine among prostate cancer patients in Taiwan: A retrospective longitudinal cohort study

International Journal of Urology

Volumn 18, Issue 5, 2011, Pages 383-386

  Lin, Yi Hsien ^a,b   Chen, Kuang Kuo ^b,d   Chiu, Jen Hwey ^c,d  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b Georgetown Univ School of Medicine   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alternative medicine; Complementary medicine; Health insurance; Prostate cancer; Traditional Chinese medicine

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; CHINESE MEDICINE; COHORT ANALYSIS; DRUG USE; HEALTH INSURANCE; HERBAL MEDICINE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; TAIWAN; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; DRUGS, CHINESE HERBAL; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; MEDICINE, CHINESE TRADITIONAL; MUSCULOSKELETAL DISEASES; OFFICE VISITS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 79955116985     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02738.x     Document Type: Article

References (20)

1. Boon H, Westlake K, Stewart M etal. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 2003; 62: 849-53.
2. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology 2005; 66: 1223-8.
3. Diefenbach MA, Hamrick N, Uzzo R etal. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J. Urol. 2003; 170: 166-9.
4. Lippert MC, McClain R, Boyd JC, Theodorescu D. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 1999; 86: 2642-8.
5. Nam RK, Fleshner N, Rakovitch E etal. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J. Urol. 1999; 161: 1521-4.
6. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur. Urol. 2003; 43: 604-8.
7. Wilkinson S, Chodak GW. Critical review of complementary therapies for prostate cancer. J. Clin. Oncol. 2003; 21: 2199-210.
8. Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan. Int. J. Clin. Oncol. 2003; 8: 26-30.
9. Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 2003; 91: 603-7.
10. Bishop FL, Rea A, Lewith H etal. Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2010 [Epub ahead of print].
11. Wong TW, Wong SL, Donnan SP. Prevalence and determinants of the use of traditional Chinese medicine in Hong Kong. Asia Pac. J. Public Health 1995; 8: 167-70.
12. Hesketh T, Zhu WX. Health in China. Traditional Chinese medicine: one country, two systems. BMJ 1997; 315: 115-17.
13. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement. Ther. Med. 2002; 10: 84-93.
14. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv. Res. 2008; 8, no. 170.
15. Eisenberg DM, Davis RB, Ettner SL etal. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75.
16. Cassidy CM. Chinese medicine users in the United States. Part I: utilization, satisfaction, medical plurality. J. Altern. Complement. Med. 1998; 4: 17-27.
17. Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement. Ther. Med. 2001; 9: 2-11.
18. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J. Clin. Oncol. 1998; 16: 6-12.
19. Chiu J, Yau T, Epstein RJ. Complications of traditional Chinese/herbal medicines (TCM) - a guide for perplexed oncologists and other cancer caregivers. Support. Care Cancer 2009; 17: 231-40.
20. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol. 2004; 5: 489-96.